Tranquility Partners, LLC Novartis Ag Transaction History

Tranquility Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$78.07 - $94.43 $225,388 - $272,619	-2,887 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $80,907 - $89,635	-985 Reduced 25.44%	2,887 $251,000
Q2 2020 Jul 29, 2020	SELL	$80.93 - $91.1 $81,334 - $91,555	-1,005 Reduced 20.61%	3,872 $338,000
Q1 2020 Apr 20, 2020	BUY	$70.67 - $99.01 $17,314 - $24,257	245 Added 5.29%	4,877 $402,000
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $5,987 - $6,598	-70 Reduced 1.49%	4,632 $403,000
Q2 2019 Aug 13, 2019	BUY	$75.4 - $92.8 $354,530 - $436,345	4,702 New	4,702 $429,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Tranquility Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Tranquility Partners, LLC with notifications on news.